
summary
|
![]() |
|
![]() |
![]() |
![]() |
Case Study: Streamlining Access for Patients with an Acute Complex ConditionDiscover how our specialty pharmacy, Biologics by McKesson helped an emerging biotech company streamline access for patients with an acute complex condition through PharmacyEliteTM, our integrated specialty pharmacy and patient access offering. |
Physician reimbursement expert Linda Rouse O’Neill, recently led the above McKesson webinar “Reimbursement Outlook for Physician Offices and Other Outpatient Settings.” O’Neill is vice president of government affairs for the Health Industry Distributors Association, the trade group that represents medical products distributors.
O’Neill discussed the scheduled Medicare reimbursement changes and quality-reporting requirements that will affect physician practices over the next two years. She forecasted major shifts in how the government—and private insurers—will pay doctors by 2020 and beyond.
“BLOCK 7: Example blockquote”
Example paragraph text
Real-world evidence (RWE) is becoming an increasingly important tool in drug development. It can be useful in areas such as value demonstration, regulatory submissions, safety and pharmacovigilance. In the ever-changing field of oncology, traditional randomized controlled trials (RCTs) have significant limitations and RWE is being embraced by researchers, regulators, clinicians and patients. In this e-book developed by experts at McKesson, we provide an overview of the use of RWE in community oncology—highlighting strengths, weaknesses and opportunities. Several case studies of RWE utilization in support of regulatory and clinical decision making in oncology are highlighted to demonstrate its importance as an evolving area in research. |
Please fill out the form to download the E-Book. Pellentesque scelerisque nulla nec ipsum finibus pharetra.
![]() |
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Your comment has been submitted successfully and will appear once a moderator approves it. You will also receive a confirmation email at [email protected] to let you know when it’s posted.
block 12: about the author
Arien Malec is vice president, data platform and acquisition tools, at RelayHealth, a healthcare information technology business unit of McKesson.
He’s also a member of the HIT Standards Committee, a federal advisory committee that advises the National Coordinator on standards, implementation, guidance and certification criteria for health IT.
block 12: about the author
Doug Biehn, vice president of Connected Care & Patient Engagement at RelayHealth, a McKesson business.
He is responsible for digital health, product strategy, development and go-to-market activities across the customer experience.